Twin Securities’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Twin Securities’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-376,669	Closed	-$25.7M	–	29
2022 Q3	$25.7M	Buy	+376,669	New	+$20.8M	11.95%	2

Other funds holding GBT

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Twin Securities's GBT Position: Q4 2022 in Review

Twin Securities sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 376,669 shares — an estimated $25.7M sold.

Twin Securities first reported a position in GBT in Q3 2022 and held it in 1 quarter. The position peaked at $25.7M in Q3 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

Twin Securities reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
Twin Securities sold 376,669 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $25.7M.
Twin Securities first reported a position in Global Blood Therapeutics, Inc. in Q3 2022 and held it in 1 quarter.
Twin Securities's Global Blood Therapeutics, Inc. position peaked at $25.7M in Q3 2022.
2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Twin Securities's 13F filing for Q4 2022, filed 14 Feb 2023.